These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34857620)

  • 1. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 1: Design and Early Results of the SNMMI Dosimetry Challenge.
    Uribe C; Peterson A; Van B; Fedrigo R; Carlson J; Sunderland J; Frey E; Dewaraja YK
    J Nucl Med; 2021 Dec; 62(Suppl 3):36S-47S. PubMed ID: 34857620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose.
    Brosch-Lenz J; Ke S; Wang H; Frey E; Dewaraja YK; Sunderland J; Uribe C
    J Nucl Med; 2023 Jul; 64(7):1109-1116. PubMed ID: 37024302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [
    Mansouri Z; Salimi Y; Akhavanallaf A; Shiri I; Teixeira EPA; Hou X; Beauregard JM; Rahmim A; Zaidi H
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1516-1529. PubMed ID: 38267686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [
    Warfvinge CF; Gustafsson J; Roth D; Tennvall J; Svensson J; Bernhardt P; Åkesson A; Wieslander E; Sundlöv A; Sjögreen Gleisner K
    J Nucl Med; 2024 Jul; 65(7):1070-1075. PubMed ID: 38724277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity.
    Brosch-Lenz J; Kurkowska S; Frey E; Dewaraja YK; Sunderland J; Uribe C
    J Nucl Med; 2024 Aug; 65(8):1166-1172. PubMed ID: 38960715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Marrow Absorbed Doses and Correlations with Hematologic Response During
    Hagmarker L; Svensson J; Rydén T; van Essen M; Sundlöv A; Gleisner KS; Gjertsson P; Bernhardt P
    J Nucl Med; 2019 Oct; 60(10):1406-1413. PubMed ID: 30902877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [
    Hebert K; Santoro L; Monnier M; Castan F; Berkane I; Assénat E; Fersing C; Gélibert P; Pouget JP; Bardiès M; Kotzki PO; Deshayes E
    J Nucl Med; 2024 Jun; 65(6):923-930. PubMed ID: 38637144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE.
    Ilan E; Sandström M; Wassberg C; Sundin A; Garske-Román U; Eriksson B; Granberg D; Lubberink M
    J Nucl Med; 2015 Feb; 56(2):177-82. PubMed ID: 25593115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After
    Dewaraja YK; Mirando DM; Peterson AB; Niedbala J; Millet JD; Mikell JK; Frey KA; Wong KK; Wilderman SJ; Nelson AS
    J Nucl Med; 2022 Nov; 63(11):1665-1672. PubMed ID: 35422445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.
    Garkavij M; Nickel M; Sjögreen-Gleisner K; Ljungberg M; Ohlsson T; Wingårdh K; Strand SE; Tennvall J
    Cancer; 2010 Feb; 116(4 Suppl):1084-92. PubMed ID: 20127957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [
    Blakkisrud J; Peterson AB; Wildermann SJ; Kingkiner G; Wong KK; Wang C; Frey KA; Stokke C; Dewaraja YK
    J Nucl Med; 2024 May; 65(5):753-760. PubMed ID: 38548350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study.
    Kayal G; Barbosa N; Marín CC; Ferrer L; Fragoso-Negrín JA; Grosev D; Gupta SK; Hidayati NR; Moalosi TCG; Poli GL; Thakral P; Tsapaki V; Vauclin S; Vergara-Gil A; Knoll P; Hobbs RF; Bardiès M
    J Nucl Med; 2024 Jan; 65(1):125-131. PubMed ID: 37884334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized dosimetry of
    Carter LM; Ocampo Ramos JC; Kesner AL
    Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34271565
    [No Abstract]   [Full Text] [Related]  

  • 14. A dosimetry procedure for organs-at-risk in
    Marin G; Vanderlinden B; Karfis I; Guiot T; Wimana Z; Reynaert N; Vandenberghe S; Flamen P
    Phys Med; 2018 Dec; 56():41-49. PubMed ID: 30527088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent
    Goetz TI; Lang EW; Prante O; Maier A; Cordes M; Kuwert T; Ritt P; Schmidkonz C
    Ann Nucl Med; 2020 Apr; 34(4):244-253. PubMed ID: 32114682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy.
    Sainz-Esteban A; Prasad V; Schuchardt C; Zachert C; Carril JM; Baum RP
    Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):501-11. PubMed ID: 22183108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radiomic- and dosiomic-based machine learning regression model for pretreatment planning in
    Plachouris D; Eleftheriadis V; Nanos T; Papathanasiou N; Sarrut D; Papadimitroulas P; Savvidis G; Vergnaud L; Salvadori J; Imperiale A; Visvikis D; Hazle JD; Kagadis GC
    Med Phys; 2023 Nov; 50(11):7222-7235. PubMed ID: 37722718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
    Boursier C; Zaragori T; Bros M; Bordonne M; Melki S; Taillandier L; Blonski M; Roch V; Marie PY; Karcher G; Imbert L; Verger A
    Eur Radiol; 2023 Oct; 33(10):7089-7098. PubMed ID: 37148355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with
    Roth D; Gustafsson J; Warfvinge CF; Sundlöv A; Åkesson A; Tennvall J; Gleisner KS
    J Nucl Med; 2022 Mar; 63(3):399-405. PubMed ID: 34272319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney dosimetry during
    Sandström M; Garske-Román U; Johansson S; Granberg D; Sundin A; Freedman N
    Acta Oncol; 2018 Apr; 57(4):516-521. PubMed ID: 28920501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.